Amnioinfusion Initiative
Open Randomized Trial Comparing Perinatal Outcome Following Expectant Management Versus Amnioinfusion in PPROM <25 Wks With Persistent Oligohydramnios
Sponsor: Catholic University, Italy
Listed as NCT00787163, this PHASE3 trial focuses on Oligohydramnios and remains ongoing. Sponsored by Catholic University, Italy, it has been updated 6 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE3
-
Aug 2018 — Jan 2021 [monthly]
Unknown Status PHASE3
-
Jun 2018 — Aug 2018 [monthly]
Unknown Status PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status PHASE3
First recorded
Sep 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Catholic University, Italy
- KU Leuven
- University of Milan
- Università degli Studi di Brescia
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Monza, Italy